This post was created by Amy Tickle, a Cancer Research UK-funded PhD student in the Cancer Prevention Group. Amy is currently in her second year… Read More »How can we monitor improvements in early diagnosis?
This post was written by Dr Jessica Barnes, psychologist/behavioural scientist and qualitative researcher in the Cancer Behavioural Science Group at King’s College London. She is… Read More »Beyond trust: collective understanding of the common good and patient data
Just over two years ago, on the 25th of May 2018, the UK government implemented the Data Protection Act across the country. This was the latest… Read More »Medical research and the double-edged sword of data protection
In this series, members of our group, the wider research field & individuals from public interest groups will debate the use of patient data in… Read More »Medical research and the common law of confidentiality
The question of “how often should women go for cervical screening?” has long been controversial. In the past, many countries recommended screening annually whereas in… Read More »Does the quality and type of screening test matter when determining safe intervals between cervical screening tests?
On 25th of May 2018 the EU General Data Protection Regulation (GDPR) went live. GDPR is designed to protect EU citizens from organisations using their data… Read More »Data protection versus health protection
The clinical director of the Irish national cervical screening programme Ireland, Dr Grainne Flannelly, resigned at the end of April. It was revealed that she… Read More »To tell or not to tell – what should we do?
A woman in the Republic of Ireland, Vicky Phelan, recently settled with a laboratory in America receiving $2.5million compensation for them missing abnormalities on her… Read More »Is it safe to export cancer screening?
